$Table 2 from Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer$

Table 2 from Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer

<p>Treatment-emergent adverse events by Common Terminology Criteria for Adverse Events v5.0, grade 1–4 occurring in at least 10% of patients and all grade 5, at the patient level.</p>

Сохранить в:

Библиографические подробности
Главный автор:	Robert W. Lentz (17013559) (author)
Другие авторы:	Julie Lang (20519739) (author), Todd M. Pitts (17013577) (author), Patrick Blatchford (22652193) (author), Junxiao Hu (16157686) (author), Kimberly R. Jordan (15049505) (author), Adrie Van Bokhoven (22652196) (author), Stacey M. Bagby (17013565) (author), Adrian T.A. Dominguez (19529151) (author), Cameron A. Binns (22652199) (author), Hannah R. Robinson (19529136) (author), Nicole Balmaceda (22652202) (author), Emily Baiyee (22652205) (author), Alexis D. Leal (17013562) (author), Sunnie S. Kim (19529139) (author), S. Lindsey Davis (14032353) (author), Christopher H. Lieu (15018279) (author), Raymond C. Wadlow (22652208) (author), Kristen Spencer (22652211) (author), Aaron J. Scott (15133937) (author), Patrick M. Boland (15037142) (author), Howard S. Hochster (15022088) (author), Wells A. Messersmith (17013568) (author)
Опубликовано:	2025
Предметы:	Cancer Immuno-oncology Clinical Research and Trials Clinical Trial Results Phase II clinical trials Checkpoint Blockade Colorectal Cancer Combination Immunotherapy Gastrointestinal Cancers Immunotherapy
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Table 2 from Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer

Схожие документы